← Back to Search

Caregiver Support Technology for Dementia

N/A
Recruiting
Led By Julie Fields, PhD, LP
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
The participant must have a family member that has been diagnosed with one of the following forms of dementia: Parkinson's/Lewy body dementia, any frontotemporal lobar degeneration dementia, or Alzheimer's dementia.
The participant must identify as a care partner or caregiver who has contact with their loved one with dementia, in person or by phone, and provides social/emotional support and full or partial assistance with daily activities at least 3 days per week.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

Summary

This trial is developing a matching process for dementia caregivers to find emotional support and reduce caregiving burden.

Who is the study for?
This trial is for caregivers who have been supporting a loved one with dementia, such as Alzheimer's or Lewy body disease, for at least 3 months. Participants must be English-speaking, able to use the internet and a computer, and willing to engage in the study activities and follow-ups over a period of 15 months.
What is being tested?
The study aims to develop a technology-based program that matches dementia caregivers for emotional support. It will test if this peer-to-peer support system can improve quality of life and reduce stress by facilitating connections through an algorithm.
What are the potential side effects?
There are no direct medical side effects from participating in this trial since it involves using technology for caregiver support rather than testing medications. However, participants may experience emotional impacts from engaging with others' experiences.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
A family member of mine has been diagnosed with Parkinson's, Lewy body dementia, frontotemporal dementia, or Alzheimer's.
Select...
I regularly help someone with dementia with their daily activities and emotional support.
Select...
I speak English.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change over time from Baseline Quality of Life to 12 months
Change over time from Baseline Resilience to 12 months
Match Satisfaction Questionnaire
+1 more
Secondary study objectives
Survey of Executive Skills

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Algorithmically MatchedExperimental Treatment1 Intervention
Individuals that identify as a current and/or former caregiver for a person with dementia will be matched to other caregivers using an algorithm that matches a caregiver to another caregiver based on specific preferences each caregiver identifies in a questionnaire.
Group II: Randomly MatchedActive Control1 Intervention
Individuals that identify as a current and/or former caregiver for a person with dementia will be randomly matched to other caregivers not based on the preferences they identified in a questionnaire.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Algorithm
2013
Completed Phase 2
~1340

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,298 Previous Clinical Trials
3,958,090 Total Patients Enrolled
25 Trials studying Dementia
16,742 Patients Enrolled for Dementia
National Institute on Aging (NIA)NIH
1,733 Previous Clinical Trials
28,054,648 Total Patients Enrolled
281 Trials studying Dementia
23,628,666 Patients Enrolled for Dementia
Minnesota HealthSolutionsIndustry Sponsor
13 Previous Clinical Trials
1,225 Total Patients Enrolled
1 Trials studying Dementia

Media Library

Algorithmically Matched Clinical Trial Eligibility Overview. Trial Name: NCT05779839 — N/A
Dementia Research Study Groups: Algorithmically Matched, Randomly Matched
Dementia Clinical Trial 2023: Algorithmically Matched Highlights & Side Effects. Trial Name: NCT05779839 — N/A
Algorithmically Matched 2023 Treatment Timeline for Medical Study. Trial Name: NCT05779839 — N/A
~34 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top